{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:40:39Z","timestamp":1760042439263},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1999,1,1]]},"DOI":"10.1212\/wnl.52.2.435","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:38:09Z","timestamp":1336916289000},"page":"435-435","source":"Crossref","is-referenced-by-count":8,"title":["Ofloxacin in the Lambert-Eaton myasthenic syndrome"],"prefix":"10.1212","volume":"52","author":[{"given":"J. R.","family":"Schottland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Sieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/WNL.52.2.435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T18:51:17Z","timestamp":1643827877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.52.2.435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,1,15]]}},"URL":"https:\/\/doi.org\/10.1212\/wnl.52.2.435","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1,1]]}}}